Nektar Therapeutics (NKTR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2013 | 12-2012 | 12-2011 | 12-2010 | 12-2009 | |
| Sales | 148,921 | 81,191 | 71,480 | 159,039 | 71,931 |
| Cost of Goods | 38,509 | 30,428 | 21,891 | 25,667 | 30,948 |
| Gross Profit | 110,412 | 50,763 | 49,589 | 133,372 | 40,983 |
| Operating Expenses | 231,051 | 192,392 | 174,417 | 162,294 | 137,063 |
| Operating Income | -120,130 | -141,201 | -123,937 | -28,255 | -95,132 |
| Interest Expense | 40,762 | 33,546 | 10,223 | 11,174 | 12,176 |
| Other Income | 1,124 | 3,298 | 1,200 | 2,372 | 4,536 |
| Pre-tax Income | -159,768 | -171,449 | -132,960 | -37,057 | -102,772 |
| Income Tax | 2,245 | 406 | 1,018 | 881 | -253 |
| Net Income Continuous | -162,013 | -171,855 | -133,978 | -37,938 | -102,519 |
| Net Income | $-162,013 | $-171,855 | $-133,978 | $-37,938 | $-102,519 |
| EPS Basic Total Ops | -1.40 | -1.50 | -1.19 | -0.40 | -1.11 |
| EPS Basic Continuous Ops | -1.40 | -1.50 | -1.19 | -0.40 | -1.11 |
| EPS Diluted Total Ops | -1.40 | -1.50 | -1.19 | -0.40 | -1.11 |
| EPS Diluted Continuous Ops | -1.40 | -1.50 | -1.19 | -0.40 | -1.11 |
| EBITDA(a) | $-105,855 | $-126,693 | $-108,986 | $-11,704 | $-80,251 |